Biotech

All Articles

Basilea ratings $268M BARDA backing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's work developing new antifungals has gotten a notable improvement from the U...

Capricor markets Europe liberties to late-stage DMD therapy for $35M

.Possessing already gathered up the U.S. civil liberties to Capricor Rehabs' late-stage Duchenne mus...

FDA junks adcomm for Applied's unusual disease drug

.After dismissing the choice meeting for Applied Therapeutics' metabolic problem medicine govorestat...

Novo inks $600M NanoVation deal to research hereditary drugs ex-liver

.Novo Nordisk is actually proceeding its press right into hereditary medicines, agreeing to compensa...

Innovent web links cytokine to colorectal cancer responses

.Innovent Biologics has created the situation that its own checkpoint inhibitor-cytokine fusion heal...

Merck, Daiichi ADC attacks goal in stage 3 lung cancer cells research study

.A stage 3 trial of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate (...

Rakovina grows artificial intelligence focus with collab to pick cancer intendeds

.5 months after Rakovina Therapies pivoted towards expert system, the cancer-focused biotech has act...

Ascendis' dwarfism medication hits in period 3, threatens BioMarin

.Ascendis Pharma has become a possible hazard to BioMarin's Voxzogo, reporting stage 3 development d...

Despite ph. 3 miss out on, Alkeus finds course in advance for eye disease asset

.Though Alkeus Pharmaceuticals' dental eye disease possession fell short to substantially minimize g...

Kairos goes social along with $6M IPO to fund trials of cancer cells medicine

.With a triad of biotechs striking the Nasdaq on Friday, it was easy to miss out on a smaller-scale ...